Baird Medical Showcases MWA Innovations at NASOIE 2025
Baird Medical Investment Holdings Ltd., a leader in microwave ablation (MWA) technology, showcased its latest innovations at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah. In a press release, the company highlighted its engagement with numerous physicians who explored the advancements in MWA technology through hands-on thyroid phantom demonstrations.
The NASOIE event, a key platform for interventional endocrinology, allowed Baird Medical to demonstrate the precision, safety, and efficiency of its MWA technology. The company's experts provided practical insights into the role of MWA in thyroid care, reinforcing Baird Medical's leadership in next-generation thyroid ablation therapies.
Baird Medical remains committed to advancing minimally invasive thyroid treatments by collaborating with medical experts and industry leaders. The insights gained from NASOIE 2025 are expected to further refine the company's MWA technology, ensuring it meets the evolving needs of thyroid care worldwide.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge Round Sep 18 OpenAI Foundation Gives UNC Lineberger $40 Million for Cancer Vaccine Research Sep 17 Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital Sep 17 Gates Foundation Commits $1 Billion to Expand AI AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Ayble Health Raises $16 Million for Virtual Digestive Care
Medtronic Invests Up to $80 Million in Pi-Cardia
Daily AI Brief: the AI news that matters, in your inbox.